Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/123,912external-prioritypatent/US6312695B1/en
Application filed by Corixa CorpfiledCriticalCorixa Corp
Publication of CO5050254A1publicationCriticalpatent/CO5050254A1/en
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents
(AREA)
Peptides Or Proteins
(AREA)
Abstract
Métodos y compuestos para el tratamiento del cáncer de pulmón.Los compuestos de la invención incluyen polipéptidos que contienen al menos una porción de una proteína de tumor pulmonar. También se proveen vacunas y composiciones farmacéuticas para inmunoterapia del cáncer de pulmón que comprenden dichos polipéptidos, o moléculas de ADN que codifican dichos polipéptidos, junto con moléculas de ADN para preparar los polipéptidos de la invención.Methods and compounds for the treatment of lung cancer.The compounds of the invention include polypeptides containing at least a portion of a lung tumor protein. Also provided are vaccines and pharmaceutical compositions for immunotherapy of lung cancer comprising said polypeptides, or DNA molecules encoding said polypeptides, together with DNA molecules to prepare the polypeptides of the invention.
CO99016779A1998-03-181999-03-18
COMPOUNDS FOR THE TREATMENT AND DIAGNOSIS OF CANCER DE PULMON
CO5050254A1
(en)
DNA SEQUENCES CODING FOR PROTEINS WITH BIOLOGICAL ACTIVITY OF HUSI TYPE-I INHIBITORS AND GENETIC TECHNOLOGICAL PROCEDURES FOR THE PREPARATION OF THESE PROTEINS.